Braingaze
The company provides eye-tracking AI software and diagnostic support tools for neurodevelopmental conditions such as ADHD and Autism. Its primary products include a 12-minute clinical assessment that captures involuntary eye movement biomarkers and a suite of gaze-controlled games designed to improve attention and focus. These solutions are marketed to clinicians, healthcare systems, and parents for the purpose of objective diagnosis and therapeutic support.
Healthtech
Diagnostics
Digital Health
Artificial Intelligence
Funding summary
- Total raised
- €1.8M
- Funding rounds
- 2
Investors in Braingaze
Investors on record for Braingaze. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Braingaze?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors